Immunomodulatory Effects of Macrolide Antibiotics - Part 1: Biological Mechanisms

被引:129
作者
Altenburg, J. [1 ]
de Graaff, C. S. [1 ]
van der Werf, T. S. [2 ]
Boersma, W. G. [1 ]
机构
[1] Med Ctr Alkmaar, Dept Pulm Dis, NL-1812 JD Alkmaar, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
关键词
Diffuse panbronchiolitis; Macrolides; Quorum sensing; BRONCHIAL EPITHELIAL-CELLS; BRONCHOALVEOLAR LAVAGE FLUID; LOW-DOSE ERYTHROMYCIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHILIC AIRWAY INFLAMMATION; CHEMICALLY-MODIFIED TETRACYCLINE; OBSTRUCTIVE PULMONARY-DISEASE; LONG-TERM THERAPY; PSEUDOMONAS-AERUGINOSA; IN-VITRO;
D O I
10.1159/000320319
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Macrolide antibiotics are well known for their antibacterial and anti-inflammatory properties. This article provides an overview of the biological mechanisms through which macrolides exert this 'double effect'. Their antibacterial effect consists of the inhibition of bacterial protein synthesis, impaired bacterial biofilm synthesis, and the attenuation of other bacterial virulence factors. Apart from these direct antimicrobial effects, macrolides are known for their modulating effect on many components of the human immune system. By influencing the production of cytokines, they have a dampening effect on the proinflammatory response. Furthermore, the majority of cells involved in the immune response are, in one way or another, influenced when macrolide antibiotics are administered. Having such an obvious effect on the various aspects of the immune system, macrolides seem to be exceptionally suited for the treatment of chronic inflammatory diseases. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:67 / 74
页数:8
相关论文
共 98 条
[1]   Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro [J].
Abdelghaffar, H ;
Vazifeh, D ;
Labro, MT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) :81-93
[2]   Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils [J].
Anderson, R ;
Theron, AJ ;
Feldman, C .
INFLAMMATION, 1996, 20 (06) :693-705
[3]   ERYTHROMYCIN SHORTENS NEUTROPHIL SURVIVAL BY ACCELERATING APOPTOSIS [J].
AOSHIBA, K ;
NAGAI, A ;
KONNO, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :872-877
[4]   Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro [J].
Asano, K ;
Kamakazu, K ;
Hisamitsu, T ;
Suzaki, H .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (11) :1913-1921
[5]   Novel effects of azithromycin on tight junction proteins in human airway epithelia [J].
Asgrimsson, V ;
Gudjonsson, T ;
Gudmundsson, GH ;
Baldursson, O .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1805-1812
[6]   Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin [J].
Baumann, U ;
Fischer, JJ ;
Gudowius, P ;
Lingner, M ;
Herrmann, S ;
Tümmler, B ;
von der Hardt, H .
INFECTION, 2001, 29 (01) :7-11
[7]   Improving mucociliary clearance in chronic obstructive pulmonary disease [J].
Bhowmik, Angshu ;
Chahal, Kamaljeet ;
Austin, Gillian ;
Chakravorty, Indranil .
RESPIRATORY MEDICINE, 2009, 103 (04) :496-502
[8]   Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin [J].
Bosnar, M ;
Kelneric, Z ;
Munic, V ;
Erakovic, V ;
Parnham, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2372-2377
[9]   Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults [J].
Capitano, B ;
Mattoes, HM ;
Shore, E ;
O'Brien, A ;
Braman, S ;
Sutherland, C ;
Nicolau, DP .
CHEST, 2004, 125 (03) :965-973
[10]   Tetracyclines and Chemically Modified Tetracycline-3 (CMT-3) Modulate Cytokine Secretion by Lipopolysaccharide-Stimulated Whole Blood [J].
Cazalis, Julia ;
Tanabe, Shin-ichi ;
Gagnon, Guy ;
Sorsa, Timo ;
Grenier, Daniel .
INFLAMMATION, 2009, 32 (02) :130-137